Company Filing History:
1 out of 59 
1 out of 1 
1 out of 1 Years Active: 1985-1990
Title: The Innovative Journey of Anna Szabolcs Nee Borbas
Introduction
Anna Szabolcs Nee Borbas, an accomplished inventor based in Budapest, Hungary, has made significant contributions to the field of pharmaceutical innovations. With three patents to her name, she has focused primarily on treating herpes infections through cutting-edge methods and compositions. Her work reflects a deep commitment to advancing healthcare through effective solutions.
Latest Patents
Among her notable patents is the "Method of treating herpes eye infections with 5-propyl-2'-deoxyuridine," which outlines a unique ophthalmic composition aimed at addressing herpes eye infections. This innovative method provides a targeted therapeutic approach using 5-propyl-2'-deoxyuridine. Furthermore, her patent titled "Topical process for treating herpes infections using 5-isopropyl-2'-.beta.-deoxyuridine" discusses an externally applicable antiviral composition that accumulates in the skin. This formulation consists of 0.2-5% by mass of 5-isopropyl-2'-.beta.-deoxyuridine, combined with conventional pharmaceutical carriers and additives.
Career Highlights
Anna's career has been marked by her tenure at various reputable institutions. She has worked at EGIS Pharmaceuticals Plc, Central Chemical Research Institute, and Biogal Pharmaceutical Works, where she honed her skills and applied her innovative ideas. Her dedication and expertise have played a crucial role in her success as an inventor.
Collaborations
Throughout her career, Anna has collaborated with esteemed colleagues, including Laszlo Tvos and Janos Sagi. These partnerships have allowed her to leverage diverse insights and further enhance her contributions to the pharmaceutical industry.
Conclusion
Anna Szabolcs Nee Borbas stands out as a prominent figure in the realm of pharmaceutical inventions, particularly in her application of antiviral treatments. With her groundbreaking patents and impactful collaborations, she continues to shape the future of healthcare and inspire innovation within her field.